#ariba_ref_name	ref_name	gene	var_only	flag	reads	cluster	ref_len	ref_base_assembled	pc_ident	ctg	ctg_len	ctg_cov	known_var	var_type	var_seq_type	known_var_change	has_known_var	ref_ctg_change	ref_ctg_effect	ref_start	ref_end	ref_nt	ctg_start	ctg_end	ctg_nt	smtls_total_depth	smtls_nts	smtls_nts_depth	var_description	free_text
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12782	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	613.4	0	.	n	.	0	C1450T	SNP	1450	1450	C	1726	1726	T	646	T	600	.	.
16S.rDNA_WHO_F_01361c	16S.rDNA_WHO_F_01361c	0	1	531	12782	16S	1529	1529	99.93	16S.l15.c4.ctg.1	2072	613.4	1	SNP	n	C1184T	0	.	.	1184	1184	C	1460	1460	C	728	C	665	16S.rDNA_WHO_F_01361c:0:1:C1184T:16S.1184T:E coli C1192T. Resistance to Spectinomycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23310	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	648.2	0	.	n	.	0	G770A	SNP	770	770	G	1115	1115	A	726	A,G,C	494,182,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23310	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	648.2	0	.	n	.	0	G1337A	SNP	1337	1337	G	1682	1682	A	781	A,G	731,1	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23310	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	648.2	0	.	n	.	0	T1971C	SNP	1971	1971	T	2316	2316	C	707	C	654	.	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23310	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	648.2	1	SNP	n	A2045G	0	.	.	2045	2045	A	2390	2390	A	714	A	664	23S.rDNA_WHO_F_01358c:0:1:A2045G:23S.2045G:E coli A2059G. High-level resistance to Azithromycin	.
23S.rDNA_WHO_F_01358c	23S.rDNA_WHO_F_01358c	0	1	659	23310	23S	2890	2890	99.9	23S.l15.c4.ctg.1	3588	648.2	1	SNP	n	C2597T	0	.	.	2597	2597	C	2942	2942	C	688	C	652	23S.rDNA_WHO_F_01358c:0:1:C2597T:23S.2597T :E coli C2611T. Low-level resistance to Azithromycin	.
folP.WHO_V_01427c	folP.WHO_V_01427c	1	1	27	1836	folP	855	855	99.88	folP.l15.c17.ctg.1	1475	123.9	1	SNP	p	R229S	1	.	.	685	687	AGC	976	978	AGC	194;191;190	A;G;C	185;183;180	folP.WHO_V_01427c:1:1:R229S:folP.228S:Resistance to sulphonamides	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4968	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3383	146.4	0	.	p	.	0	D95A	NONSYN	283	285	GAC	637	639	GCC	147;144;143	G;C;C	142;141;140	.	.
gyrA.WHO_G_01105	gyrA.WHO_G_01105	1	1	539	4968	gyrA	2751	2751	99.96	gyrA.l15.c4.ctg.1	3383	146.4	1	SNP	p	S91F	1	.	.	271	273	TTC	625	627	TTC	150;150;147	T;T;C	139;138;136	gyrA.WHO_G_01105:1:1:S91F:gyrA.91F:Resistance to fluoroquinolones	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1424	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1258	112.6	0	.	p	.	0	A39T	NONSYN	115	117	GCC	441	443	ACC	169;168;167	A;C;C	156;156;159	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1424	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1258	112.6	0	.	p	.	0	Y105H	NONSYN	313	315	TAC	639	641	CAC	171;170;171	C;A;C	159;157;158	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1424	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1258	112.6	0	.	p	.	0	A127fs	FSHIFT	379	379	G	705	705	G	169	G	164	.	.
mtrR.WHO_X_01389	mtrR.WHO_X_01389	1	1	531	1424	mtrR	633	633	99.06	mtrR.l15.c4.ctg.1	1258	112.6	1	SNP	p	G45D	0	.	.	133	135	GGC	459	461	GGC	165;166;169	G;G;C	157;159;162	mtrR.WHO_X_01389:1:1:G45D:mtrR.45D:Increased efflux of antimicrobials, e.g. macrolides and b-lactam antimicrobials, that are substrates of the MtrCDE efflux pump	.
mtrR_promoter.WHO_F	mtrR_promoter.WHO_F	0	0	19	730	mtrR_promoter	250	250	100.0	mtrR_promoter.l15.c17.ctg.1	760	94.5	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4420	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2948	149.4	0	.	p	.	0	S87N	NONSYN	259	261	AGT	604	606	AAT	194;192;192	A;A;T	179;178;175	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4420	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2948	149.4	0	.	p	.	0	I384V	NONSYN	1150	1152	ATC	1495	1497	GTC	199;199;198	G,A;T;C	180,1;177;180	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4420	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2948	149.4	0	.	p	.	0	V435A	NONSYN	1303	1305	GTG	1648	1650	GCA	183;183;183	G;C;A	173;170;168	.	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4420	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2948	149.4	1	SNP	p	D86N	0	.	.	256	258	GAC	601	603	GAC	193;193;194	G;A;C,A	180;174;179,1	parC.WHO_M_00204c:1:1:D86N:parC.86N:Resistance to fluoroquinolones	.
parC.WHO_M_00204c	parC.WHO_M_00204c	1	1	539	4420	parC	2304	2304	99.7	parC.l15.c4.ctg.1	2948	149.4	1	SNP	p	S88P	0	.	.	262	264	TCC	607	609	TCC	190;194;194	T;C;C	174;177;181	parC.WHO_M_00204c:1:1:S88P:parC.88P:Resistance to fluoroquinolones	.
parE.WHO_F_01528c	parE.WHO_F_01528c	1	1	27	3930	parE	1986	1986	99.95	parE.l6.c4.ctg.1	2509	155.5	1	SNP	p	G410V	0	.	.	1228	1230	GGC	1445	1447	GGC	176;173;172	G;G;C	166;161;162	parE.WHO_F_01528c:1:1:G410V:parE.410V:Resistance to fluoroquinolones	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	A311V	0	.	.	931	933	GCA	1350	1352	GCA	194;193;194	G;C;A	184;186;186	penA.19.001:1:1:A311V:penA.311V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	I312M	0	.	.	934	936	ATC	1353	1355	ATC	191;192;193	A;T;C	180;182;182	penA.19.001:1:1:I312M:penA.312M:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	V316P	0	.	.	946	948	GTG	1365	1367	GTG	191;192;197	G;T;G	180;176;182	penA.19.001:1:1:V316P:penA.316P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	V316T	0	.	.	946	948	GTG	1365	1367	GTG	191;192;197	G;T;G	180;176;182	penA.19.001:1:1:V316T:penA.316T:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	T484S	0	.	.	1450	1452	ACC	1869	1871	ACC	189;189;188	A;C;C	175;176;177	penA.19.001:1:1:T484S:penA.483S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	A502V	0	.	.	1504	1506	GCG	1923	1925	GCG	192;188;192	G;C;G	168;150;157	penA.19.001:1:1:A502V:penA.501V:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	A502P	0	.	.	1504	1506	GCG	1923	1925	GCG	192;188;192	G;C;G	168;150;157	penA.19.001:1:1:A502P:penA.501P:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	G543S	0	.	.	1627	1629	GGT	2046	2048	GGT	168;167;166	G;G;T	154;154;152	penA.19.001:1:1:G543S:penA.542S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	G546S	0	.	.	1636	1638	GGC	2055	2057	GGC	167;169;167	G;G;C	148;151;150	penA.19.001:1:1:G546S:penA.545S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
penA.19.001	penA.19.001	1	1	27	3776	penA	1752	1752	100.0	penA.l15.c30.ctg.1	2521	149.4	1	SNP	p	P552S	0	.	.	1654	1656	CCG	2073	2075	CCG	153;153;150	C,G;C,T;G	108,2;113,1;104	penA.19.001:1:1:P552S:penA.551S:Resistance to Extended-Spectrum Cephalosporins (ESCs)	.
ponA.WHO_G_00106	ponA.WHO_G_00106	1	1	27	5378	ponA	2397	2397	100.0	ponA.l15.c4.ctg.1	3021	177.2	1	SNP	p	L421P	1	.	.	1261	1263	CCG	1576	1578	CCG	193;191;188	C;C;G	170;174;171	ponA.WHO_G_00106:1:1:L421P:ponA.421P:High-level chromosomally-mediated penicillin resistance	.
porA.NCCP11945	porA.NCCP11945	1	0	531	2044	porA	1146	1146	99.65	porA.l15.c4.ctg.1	1831	111.1	0	.	p	.	0	M83fs	FSHIFT	247	247	A	481	481	C	155	C	139	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	V258L	NONSYN	772	774	GTA	64	66	TTA	50;51;51	T;T;A	43;44;44	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	Y273H	NONSYN	817	819	TAT	109	111	CAT	51;50;47	C;A;T	46;45;43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	D274S	NONSYN	820	822	GAT	112	114	AGT	47;47;48	A;G;T	43;42;43	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	N277Y	NONSYN	829	831	AAC	121	123	TAC	49;49;50	T;A;C	44;44;44	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	R307E	NONSYN	919	921	AGA	211	213	GAA	16;16;16	G,A;A,G;A	15,1;15,1;16	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	T311A	NONSYN	931	933	ACA	223	225	GCA	14;14;14	G,A;C;A	13,1;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	F314I	NONSYN	940	942	TTC	232	234	ATC	13;14;14	A,T;T;C	12,1;14;14	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	A316S	NONSYN	946	948	GCG	238	240	TCG	12;12;12	T,G;C;G	11,1;12;12	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	V318A	NONSYN	952	954	GTC	244	246	GCC	13;13;13	G;C,T;C	13;12,1;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	G319S	NONSYN	955	957	GGC	247	249	AGC	13;13;13	A,G;G;C	12,1;13;13	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	G320A	NONSYN	958	960	GGT	250	252	GCC	14;14;14	G;C,G;C,T	14;13,1;13,1	.	.
porB1a.WHO_N_02200c	porB1a.WHO_N_02200c	1	0	528	272	porB1a	984	271	92.25	porB1a.l15.c30.ctg.2	352	28.6	0	.	p	.	0	G322V	NONSYN	964	966	GGT	256	258	GTT	15;15;15	G;T,G;T	15;14,1;15	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	0	.	p	.	0	R143G	NONSYN	427	429	AGA	698	700	GGA	208;206;206	G,C;G,A;A	187,1;185,1;189	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	0	.	p	.	0	.	INDELS	629	630	AA	901	903	TAG	191;189;188	T,C;A;G	182,1;180;177	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	0	.	p	.	0	.	MULTIPLE	631	633	TAC	905	908	CAAT	191;191;189;187	C,A;A;A;T	181,1;185;184;181	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	0	.	p	.	0	N212fs	FSHIFT	634	634	A	910	910	T	191	T	182	.	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	1	SNP	p	G120K	0	.	.	358	360	GGT	629	631	GGT	209;203;203	G,A;G;T,A	188,1;185;176,1	porB1b.WHO_U_02278c:1:1:G120K:porB1b.120K:G101K. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	1	SNP	p	A121D	0	.	.	361	363	GCC	632	634	GCC	206;204;201	G;C;C,T	186;184;181,1	porB1b.WHO_U_02278c:1:1:A121D:porB1b.121D:A102D. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
porB1b.WHO_U_02278c	porB1b.WHO_U_02278c	1	1	539	2418	porB1b	1035	1035	98.38	porB1b.l6.c4.ctg.1	1570	153.1	1	SNP	p	A121N	0	.	.	361	363	GCC	632	634	GCC	206;204;201	G;C;C,T	186;184;181,1	porB1b.WHO_U_02278c:1:1:A121N:porB1b.121N:A102N. Mediates decreased permeability of antimicrobials through the porin PorB1b	.
rpoB.WHO_F_02153c	rpoB.WHO_F_02153c	1	1	539	9586	rpoB	4179	4179	99.98	rpoB.l15.c4.ctg.1	4842	197.6	1	SNP	p	H553N	1	H553N	NONSYN	1657	1659	CAT	2004	2006	AAT	207;207;208	A;A;T	198;198;197	rpoB.WHO_F_02153c:1:1:H553N:rpoB.553N:H552N. High-level resistance to Rifampicin	.
rpsJ.WHO_Y_02241	rpsJ.WHO_Y_02241	1	1	27	1068	rpsJ	312	312	100.0	rpsJ.l15.c4.ctg.1	864	122.8	1	SNP	p	V57M	1	.	.	169	171	ATG	451	453	ATG	258;259;255	A;T;G	235;233;231	rpsJ.WHO_Y_02241:1:1:V57M:rpsJ.57M:Chromosomally-mediated resistance to tetracyclines	.
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	M177T	NONSYN	529	531	ATG	1014	1016	ACG	359;358;358	A;C;G	348;347;344	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	Y184D	NONSYN	550	552	TAC	1035	1037	GAC	310;308;308	G;A;C	307;303;306	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	T190M	NONSYN	568	570	ACG	1053	1055	ATG	297;292;289	A;T;G	296;289;286	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	L194S	NONSYN	580	582	TTA	1065	1067	TCA	274;275;271	T;C,T;A	274;273,1;271	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	H209Q	NONSYN	625	627	CAT	1110	1112	CAG	275;277;280	C;A,G;G	272;272,1;277	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	V216L	NONSYN	646	648	GTT	1131	1133	CTT	284;286;285	C;T;T	279;283;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	N223S	NONSYN	667	669	AAC	1152	1154	AGT	293;294;300	A,C;G;T	278,1;279;282	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	Q246P	NONSYN	736	738	CAG	1221	1223	CCG	435;439;442	C,T;C;G	406,1;407;417	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	P280S	NONSYN	838	840	CCG	1323	1325	TCG	526;522;523	T;C,A;G	488;483,1;484	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	E337K	NONSYN	1009	1011	GAG	1494	1496	AAA	273;273;268	A;A;A	264;263;257	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	R338K	NONSYN	1012	1014	AGA	1497	1499	AAG	254;252;248	A;A;G	246;246;238	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	L343H	NONSYN	1027	1029	CTC	1512	1514	CAC	229;227;229	C,T;A;C	222,1;215;226	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	Q356E	NONSYN	1066	1068	CAA	1551	1553	GAA	191;190;190	G,T;A;A	188,1;190;189	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	A382T	NONSYN	1144	1146	GCG	1629	1631	ACG	130;130;129	A;C;G	130;130;129	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	T399I	NONSYN	1195	1197	ACT	1680	1682	ATT	212;212;214	A;T;T	200;199;202	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	C400S	NONSYN	1198	1200	TGT	1683	1685	AGT	214;214;213	A;G;T	202;203;201	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	I413L	NONSYN	1237	1239	ATA	1722	1724	CTA	238;238;242	C;T,A;A	224;223,1;226	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	K427N	NONSYN	1279	1281	AAA	1764	1766	AAT	171;171;173	A;A;T	163;162;163	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	A450S	NONSYN	1348	1350	GCA	1833	1835	TCA	215;214;218	T;C;A	207;207;208	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	V458M	NONSYN	1372	1374	GTA	1857	1859	ATG	234;235;241	A;T;G	223;226;231	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	N556T	NONSYN	1666	1668	AAC	2151	2153	ACC	519;512;518	A;C;C	477;478;479	.	Tetracycline resistance
tetM.WHO_G_pTetM_00047	tetM.WHO_G_pTetM_00047	1	0	539	9128	tetM	1920	1920	96.3	tetM.l15.c4.ctg.1	2706	336.5	0	.	p	.	0	K588E	NONSYN	1762	1764	AAA	2247	2249	GAA	526;523;520	G;A;A	497;498;494	.	Tetracycline resistance
